Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - OTHER FINANCING ACTIVITIES
Other Financing Activities ABUS - Arbutus Biopharma Corporation
795 K
LAST VALUE
-76.75%
2 YEAR CAGR
-60.01%
5 YEAR CAGR
1.60%
10 YEAR CAGR